THN391 clinical trials

A Study to Assess THN391 in Subjects With Alzheimer's Disease

This study is for people aged 65-85 with early Alzheimer's and small vessel disease. It tests a new drug, THN391, or a dummy drug, over 6 months to see if it's safe and how it behaves in the body. It involves clinic visits, scans, and memory tests.